Apogee Therapeutics, Inc. APGE
- zumilokibart — Atopic Dermatitis Phase 2
- zumilokibart — Asthma Phase 1
- APG279 — Atopic Dermatitis Phase 1
- APG273 — Asthma Preclinical
- APG273 — Chronic Obstructive Pulmonary Disease Preclinical
IL-13 (1 companies · 5 programs)
Companies with an active program directed at IL-13.